Decreased skin reactivity to codeine in patients with the acquired immunodeficiency syndrome

Clinical Immunology and Immunopathology

Volumn 81, Issue 1, 1996, Pages 12-15

  Simonart, Th ^a   Parent, D ^a   Heenen, M ^a   Farber, C M ^a   Van Vooren, J P ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE PHOSPHATE; HISTAMINE; IMMUNOGLOBULIN E;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPERSENSITIVITY REACTION; INTRADERMAL DRUG ADMINISTRATION; MALE; MAST CELL DEGRANULATION; PRIORITY JOURNAL; SKIN ALLERGY; URTICARIA;

EID: 0030271431     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0150     Document Type: Article

References (20)

1. 1. Bayard, P. J., Berger, T. G., and Jacobson, M. A., Drug hypersensitivity reactions and human immunodeficiency virus disease. J. Acquired Immune Defic. Syndr. 5, 1237-1257, 1992.
2. 2. Coopman, S. A., Johnson, R. A., Platt, R., and Stern, R. S., Cutaneous disease and drug reactions in HIV infection. N. Engl. J. Med. 328, 1670-1674, 1993.
3. 3. Carr, A., Vasak, E., Munro, V., Penny, R., and Cooper, D. A., Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection. Clin. Exp. Immunol. 97, 260-265, 1994.
4. 4. Koopmans, P. P., Van der Ven, A. J., Vree, T. B., and Van der Meer, J. W. M., Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS 9, 217-222, 1995.
5. 5. Van der Ven, A. J., Koopmans, P. P., Vree, T. B., and Van der Meer, J. W. M., Adverse reactions to co-trimoxazole in HIV infection. Lancet 338, 431-433, 1991.
6. 6. Rieder, M. J., Krause, R., Bird, I. A., and Dekaban, G. A., Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells. J. Acquired Immune Defic. Syndr. 8, 134-140, 1995.
7. 7. Kelly, J. W., Dooley, D. P., Lattuada, C. P., and Smith, C. E., A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 14, 1034-1039, 1992.
8. 8. Israel-Biet, D., Labrousse, F., Tourani, J. M., Sors, H., Andrieu, J. M., and Even, P., Elevation of IgE in HIV-infected subjects: A marker of poor prognosis. J. Allergy Clin. Immunol. 89, 68-75, 1992.
9. 9. Mazza, D. S., Grieco, M. H., Reddy, M. M., and Meriney, D., Serum IgE in patients with human immunodeficiency virus infection. Ann. Allergy 74, 411-414, 1995.
10. 10. Miadonna, A., Leggieri, E., Tedeschi, A., Lazzarin, L., Chianura, L., Froldi, M., and Zanussi, C., Enhanced basophil releasibility in subjects infected with human immunodeficiency virus. Clin. Immunol. Immunopathol. 54, 237-246, 1990.
11. 11. Pedersen, M., Permin, H., Jensen, C., Skov, B. S., Norn, S., and Faber, V., Histamine release from basophils leukocytes induced by microbial antigen preparations in patients with AIDS. Allergy 42, 291-297, 1987.
12. 12. Pedersen, M., Nielsen, C. M., and Permin, H., HIV antigen-induced release of histamine from basophils from HIV infected patients. Allergy 46, 206-212, 1991.
13. 13. Elson, C. O., Kagnoff, M. F., Fiocchi, C., Befus, A. D., and Targan, S., Intestinal immunity and inflammation: Recent progress. Gastroenterology 91, 746-768, 1986.
14. 14. Schwartz, L. B., and Kepley, C. Development of markers for human basophils and mast cells. J. Allergy Clin. Immunol. 94, 1231-1240, 1994.
15. 15. Yman, L., New developments in serum IgE measurement: IgE reference values (adults and children). Allergy 40(Suppl. 4), 10-11, 1985.
16. 16. Cohen, R. W., and Rosenstreich, D. L., Discrimination between uritcaria-prone and other allergic patients by intradermal skin testing with codeine. J. Allergy Clin. Immunol. 77, 802-807, 1986.
17. 17. Liotet, S., Meyohas, M. C., Batellier, L., Chaumeil, C., Sainte Laudy, J., Fribourg Blanc, A., and Frottier, J., Histaminémie des malades infectés par le virus de l'immunodéficience humaine. Presse Méd. 17, 2240-2242, 1988.
18. 18. Galli, S. J., New concepts about the mast cell. N. Engl. J. Med. 328, 257-265, 1993.
19. 19. Levi, G., Patrizio, M., Bernardo, A., Petrucci, T. C., and Agresti, C., Human immunodeficiency virus coat protein gp 120 inhibits the β-adrenergic regulation of astroglial and microglial functions. Proc. Natl. Acad. Sci. USA 90, 1541-1545, 1993.
20. 20. Marone, G., Spadaro, G., Patella, V., and Genovese, A., The clinical relevance of basophil releasibility. J. Allergy Clin. Immunol. 94, 1293-1303, 1994.